As Of June 30, 2024, Phathom Pharmaceuticals' Cash And Cash Equivalents Were $276.2M, The Company Believes It Will Have Sufficient Capital To Fund Operations Through The End Of 2026
As Of June 30, 2024, Phathom Pharmaceuticals' Cash And Cash Equivalents Were $276.2M, The Company Believes It Will Have Sufficient Capital To Fund Operations Through The End Of 2026
截至2024年6月30日，phathom pharmaceuticals的現金及現金等價物爲276.2百萬美元，公司認爲將有足夠資本支持運營至2026年底。
As Of June 30, 2024, Phathom Pharmaceuticals' Cash And Cash Equivalents Were $276.2M, The Company Believes It Will Have Sufficient Capital To Fund Operations Through The End Of 2026
截至2024年6月30日，phathom pharmaceuticals的現金及現金等價物爲276.2百萬美元，公司認爲將有足夠資本支持運營至2026年底。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間